[
    [
        {
            "time": "",
            "original_text": "实际控制人签订虚假合同套取3294.87万元？贵州益佰制药收警示函 其他违规处罚",
            "features": {
                "keywords": [
                    "实际控制人",
                    "虚假合同",
                    "套取资金",
                    "贵州益佰制药",
                    "警示函",
                    "违规处罚"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "实际控制人签订虚假合同套取3294.87万元？贵州益佰制药收警示函 其他违规处罚",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]